Neutral
CNS Pharmaceuticals (NASDAQ: CNSP) details CEO transition, pay and ownership in 10-K/A
CNS Pharmaceuticals (CNSP) filed an amended annual report (10-K/A) to update information
CNSP
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest CNSP News
Research CNSP on:
Ad Space